The treatment with exogenous 5-HETE led to no change in cell viability, with the exception of U251-MG (Figure 3A); therefore, the possible interaction between GBM cells and 5-LOX products derived from the microenvironment should not be discarded. Here, ALOX5 is linked to glioblastoma.